Crossmark

Toxicological evaluation of therapeutic and supra-therapeutic doses of Cellgevity® on reproductive function and biochemical indices in Wistar rats

Crossref DOI link: https://doi.org/10.1186/s40360-018-0253-y

Published Online: 2018-10-25

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Awodele, O.

Badru, W. A.

Busari, A. A.

Kale, O. E.

Ajayi, T. B.

Udeh, R. O.

Emeka, P. M.
License Information

Text and Data Mining valid from 2018-10-25
More Information

Article History

Received: 21 August 2017

Accepted: 1 October 2018

First Online: 25 October 2018

Ethics approval and consent to participate

: This study was approved by the University of Lagos, Nigeria ethical committee on the use of animals, and conformed to the Guide for the Care and Use of Laboratory Animals published by the U. S. National Institutes of Health (NIH Publication No. 85–23, revised 1996)” for studies involving experimental animals.

: Not Applicable.

: This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors. The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.